ArticleCureus2026
Speech-Triggered Neurogenic Cough Following Slow Pathway Ablation for Atrioventricular Nodal Reentrant Tachycardia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persistent cough following catheter ablation for atrioventricular nodal reentrant tachycardia (AVNRT) is not a recognized complication. We report the case of an 81-year-old man who developed a persistent, speech-triggered dry cough beginning the day after successful slow pathway ablation. The cough was reproducibly provoked by phonation, absent during sleep, and persisted despite an unrevealing cardiopulmonary and inflammatory evaluation. To our knowledge, this phenotype has not been previously described following slow pathway ablation for AVNRT. Unlike post-ablation cough reported in left atrial and pulmonary vein procedures, where pulmonary, esophageal, phrenic, and autonomic mechanisms are well-characterized, slow pathway ablation targets the posteroseptal right atrium, a region not previously implicated in cough-related complications, making this a mechanistically distinct presentation. We propose a post-procedural neurogenic mechanism involving transient sensitization of vagal afferent pathways in the posteroseptal slow pathway region, consistent with a laryngeal hypersensitivity phenotype. Symptoms improved after colchicine, suggesting a limited inflammatory contribution to neural sensitization. This case expands the spectrum of potential complications after AVNRT ablation and may help guide recognition of atypical post-procedural symptoms while avoiding unnecessary diagnostic evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.